Clinical Trials Logo

Clinical Trial Summary

This study will assess safety, tolerability, and effect of LCQ908 on blood lipids in patients with severe hypertriglyceridemia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01146522
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 2010
Completion date October 2011

See also
  Status Clinical Trial Phase
Completed NCT00000538 - Dietary Effects on Lipoproteins and Thrombogenic Activity Phase 3
Completed NCT01645046 - The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia Phase 2
Recruiting NCT01928342 - The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia Phase 2/Phase 3
Terminated NCT01239992 - Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia Phase 4
Completed NCT02933138 - Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia N/A
Completed NCT01878227 - Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia Phase 3
Completed NCT01811082 - Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia Phase 3
Active, not recruiting NCT05256654 - A Study of LY3561774 in Participants With Mixed Dyslipidemia Phase 2
Completed NCT00005128 - Lipid Research Clinics Population Studies N/A
Completed NCT01057654 - A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin Phase 3
Completed NCT00001226 - Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins N/A